Mark Kavulich

Mr. Kavulich joined Athyrium in 2017 and currently serves as a Partner. He previously served as a Principal and as a Vice President. Since joining Athyrium, Mr. Kavulich has been actively involved with numerous investments, including growth equity and private equity style investments, fixed income and special situations. He participates in all major investment functions including origination, transaction execution, portfolio company development, and monetization events.

Mr. Kavulich has experience in both private and public market investing across the U.S. and Europe. His sub-sector experience includes specialty and OTC pharmaceuticals, pharma services, medical devices, healthcare services, and healthcare IT.

Prior to joining Athyrium, Mr. Kavulich was a Vice President at Avista Capital Partners, a middle market private equity firm, where he primarily focused on investments in the Healthcare industry, including leveraged buyouts, mergers, acquisitions, and growth equity investments. He formerly served as an Associate at Avista.

Prior to Avista, Mr. Kavulich served as an Analyst in the financial sponsors and leveraged finance groups at Morgan Stanley.

Mr. Kavulich received a B.S. in Foreign Service with a concentration in International Economics, Finance and Commerce and proficiency in Chinese from Georgetown University.